These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Acoustic analysis of functional dysphonia: before and after voice therapy (accent method). Fex B; Fex S; Shiromoto O; Hirano M J Voice; 1994 Jun; 8(2):163-7. PubMed ID: 8061772 [TBL] [Abstract][Full Text] [Related]
23. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease. Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888 [TBL] [Abstract][Full Text] [Related]
26. [Results of voice therapy in functional voice disorders]. Birkent H; Akçam T; Gerek M; Ertaş I; Ozkaptan Y Kulak Burun Bogaz Ihtis Derg; 2004; 12(5-6):120-7. PubMed ID: 16020987 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of voice therapy assessed with the Voice Range Profile (Phonetogram). DeJonckere PH; van Wijck I; Speyer R Rev Laryngol Otol Rhinol (Bord); 2003; 124(5):285-9. PubMed ID: 15144023 [TBL] [Abstract][Full Text] [Related]
28. Multidimensional Voice Program (MDVP) and amplitude variation parameters in euphonic adult subjects. Normative study. Nicastri M; Chiarella G; Gallo LV; Catalano M; Cassandro E Acta Otorhinolaryngol Ital; 2004 Dec; 24(6):337-41. PubMed ID: 15952683 [TBL] [Abstract][Full Text] [Related]
29. Twelve-month clinical follow-up study of voice patients' recovery using the Voice Activity and Participation Profile (VAPP). Kleemola L; Helminen M; Rorarius E; Sihvo M; Isotalo E J Voice; 2011 Sep; 25(5):e245-54. PubMed ID: 21050712 [TBL] [Abstract][Full Text] [Related]
30. High-frequency components of normal and dysphonic voices. Valencia Naranjo N; Mendoza Lara E; Mateo Rodríguez I; Carballo García G J Voice; 1994 Jun; 8(2):157-62. PubMed ID: 8061771 [TBL] [Abstract][Full Text] [Related]
31. The reliability and validity of patient self-rating of their own voice quality. Lee M; Drinnan M; Carding P Clin Otolaryngol; 2005 Aug; 30(4):357-61. PubMed ID: 16209679 [TBL] [Abstract][Full Text] [Related]
32. Revisiting the pitch controversy: changes in speaking fundamental frequency (SFF) after management of functional dysphonia. Roy N; Hendarto H J Voice; 2005 Dec; 19(4):582-91. PubMed ID: 16301104 [TBL] [Abstract][Full Text] [Related]
33. Acoustic measures of dysphonic severity across and within voice types. Wolfe V; Fitch J; Martin D Folia Phoniatr Logop; 1997; 49(6):292-9. PubMed ID: 9415734 [TBL] [Abstract][Full Text] [Related]
34. Mutational falsetto: intervention outcomes in 45 patients. Dagli M; Sati I; Acar A; Stone RE; Dursun G; Eryilmaz A J Laryngol Otol; 2008 Mar; 122(3):277-81. PubMed ID: 17524172 [TBL] [Abstract][Full Text] [Related]
35. Voice outcome measures: correlations with patients' assessment of their condition and the effectiveness of voice therapy. Fulljames N; Harris S Logoped Phoniatr Vocol; 2006; 31(1):23-35. PubMed ID: 16531288 [TBL] [Abstract][Full Text] [Related]
36. Objective assessment of voice intervention: a clinical audit. Lockhart MS Int J Lang Commun Disord; 1998; 33 Suppl():316-21. PubMed ID: 10343712 [TBL] [Abstract][Full Text] [Related]
37. Vocal Control: Is It Susceptible to the Negative Effects of Self-Regulatory Depletion? Vinney LA; van Mersbergen M; Connor NP; Turkstra LS J Voice; 2016 Sep; 30(5):638.e21-31. PubMed ID: 26804788 [TBL] [Abstract][Full Text] [Related]
38. Reliability of speaking and maximum voice range measures in screening for dysphonia. Ma E; Robertson J; Radford C; Vagne S; El-Halabi R; Yiu E J Voice; 2007 Jul; 21(4):397-406. PubMed ID: 16678387 [TBL] [Abstract][Full Text] [Related]
39. Characterization of effective primary voice therapy for dysphonia. Sellars C; Carding PN; Deary IJ; MacKenzie K; Wilson JA J Laryngol Otol; 2002 Dec; 116(12):1014-8. PubMed ID: 12537614 [TBL] [Abstract][Full Text] [Related]